{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:04:24Z","timestamp":1790622264990,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,12]],"date-time":"2016-08-12T00:00:00Z","timestamp":1470960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.antiviral.2016.08.012","type":"journal-article","created":{"date-parts":[[2016,8,15]],"date-time":"2016-08-15T04:03:52Z","timestamp":1471233832000},"page":"218-222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"special_numbering":"C","title":["Treatment of Lassa virus infection in outbred guinea pigs with first-in-class\u00a0human monoclonal antibodies"],"prefix":"10.1016","volume":"133","author":[{"given":"Robert W.","family":"Cross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad E.","family":"Mire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis M.","family":"Branco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan B.","family":"Geisbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan M.","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan L.","family":"Heinrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augustine","family":"Goba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mambu","family":"Momoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald S.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Fullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheik Humarr","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Geisbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5683-3250","authenticated-orcid":false,"given":"Robert F.","family":"Garry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2016.08.012_bib1","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.3201\/eid1610.100774","article-title":"Imported Lassa fever, Pennsylvania, USA, 2010","volume":"16","author":"Amorosa","year":"2010","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.08.012_bib2","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1086\/657315","article-title":"Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever","volume":"51","author":"Bausch","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.08.012_bib3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/pgmj.67.784.193","article-title":"Exchange transfusion of a patient with fulminant Lassa fever","volume":"67","author":"Cummins","year":"1991","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.antiviral.2016.08.012_bib4","doi-asserted-by":"crossref","first-page":"e388","DOI":"10.1371\/journal.pntd.0000388","article-title":"Risk maps of Lassa fever in west Africa","volume":"3","author":"Fichet-Calvet","year":"2009","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2016.08.012_bib5","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/374853","article-title":"Imported Lassa fever in Germany: surveillance and management of contact persons","volume":"36","author":"Haas","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.08.012_bib6","first-page":"71","article-title":"The first imported case of Lassa fever in Japan","volume":"47","author":"Hirabayashi","year":"1989","journal-title":"Nihon Rinsho"},{"key":"10.1016\/j.antiviral.2016.08.012_bib7","first-page":"55","article-title":"Lassa fever: the challenges of curtailing a deadly disease","volume":"11","author":"Ibekwe","year":"2012","journal-title":"Pan Afr. Med. J."},{"key":"10.1016\/j.antiviral.2016.08.012_bib8","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/0035-9203(85)90388-8","article-title":"Endemic Lassa fever in Liberia. IV. Selection of optimally effective plasma for treatment by passive immunization","volume":"79","author":"Jahrling","year":"1985","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2016.08.012_bib9","doi-asserted-by":"crossref","first-page":"677","DOI":"10.4269\/ajtmh.1970.19.677","article-title":"Lassa fever, a new virus disease of man from west Africa. II. Report of a laboratory-acquired infection treated with plasma from a person recently recovered from the disease","volume":"19","author":"Leifer","year":"1970","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2016.08.012_bib10","doi-asserted-by":"crossref","first-page":"g5488","DOI":"10.1136\/bmj.g5488","article-title":"US signs contract with ZMapp maker to accelerate development of the Ebola drug","volume":"349","author":"McCarthy","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.antiviral.2016.08.012_bib11","first-page":"433","article-title":"Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants","volume":"2","author":"Mejias","year":"2008","journal-title":"Biologics"},{"key":"10.1016\/j.antiviral.2016.08.012_bib12","doi-asserted-by":"crossref","first-page":"11544","DOI":"10.1038\/ncomms11544","article-title":"Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits","volume":"7","author":"Robinson","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2016.08.012_bib13","doi-asserted-by":"crossref","first-page":"14775","DOI":"10.1038\/srep14775","article-title":"The broad-spectrum antiviral favipiravir protects Guinea pigs from lethal Lassa virus infection post-disease onset","volume":"5","author":"Safronetz","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2016.08.012_bib14","doi-asserted-by":"crossref","first-page":"e2748","DOI":"10.1371\/journal.pntd.0002748","article-title":"Lassa fever in post-conflict Sierra Leone","volume":"8","author":"Shaffer","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2016.08.012_bib15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/jmv.1890140402","article-title":"Effect of environmental factors on aerosol-induced Lassa virus infection","volume":"14","author":"Stephenson","year":"1984","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.antiviral.2016.08.012_bib16","series-title":"WHO Publishes List of Top Emerging Diseases Likely to Cause Major Epidemics","author":"WHO","year":"2016"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216303515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216303515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,9]],"date-time":"2018-09-09T02:30:28Z","timestamp":1536460228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216303515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":16,"alternative-id":["S0166354216303515"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.08.012","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726648514.793555410","asserted-by":"object"}]},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Lassa virus infection in outbred guinea pigs with first-in-class\u00a0human monoclonal antibodies","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}